• Info
  • Insider Ownership

Insider Trading & Ownership of Andrew J. Einhorn

Location
Durham, NC
Summary
The estimated net worth of Andrew J. Einhorn is at least $347,127 dollars as of 29 Dec 2025. Andrew J. Einhorn is the Director of Pelthos Therapeutics Inc. and owns shares of Pelthos Therapeutics Inc. (PTHS) stock worth about $342K. Andrew J. Einhorn is the Chief Financial Officer of RVL Pharmaceuticals plc and owns shares of RVL Pharmaceuticals plc stock worth about $5.1K.
Signature
/s/ Andrew J. Einhorn
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Andrew J. Einhorn and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Andrew J. Einhorn has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $347,127.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Pelthos Therapeutics Inc. ($342,000).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Andrew J. Einhorn

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
PTHS Pelthos Therapeutics Inc. Director $342,000 23 Dec 2025
RVLP RVL Pharmaceuticals plc Chief Financial Officer $5,127 24 Jan 2022
CGTX COGNITION THERAPEUTICS INC Interim CFO 12 Aug 2022

Insider Transactions Reported by Andrew J. Einhorn:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored